Severson. .. Abaxis third quarter revenues increase 32 percent to $49.8 million Abaxis, Inc. , a medical products business manufacturing point-of-care blood evaluation systems, today reported monetary results for the 3rd fiscal quarter ended December 31, 2012. Record quarterly highlights include: Revenues of $49.8 million, up 32 percent over last year's comparable quarter. THE UNITED STATES revenues of $41.8 million, up 31 percent over last year's comparable quarter. Medical market revenues of $9.0 million, up 10 percent over last year's comparable quarter. Veterinary market revenues of $39.9 million, up 40 percent over last year's comparable quarter.This lack of trust by doctors is definitely spilling over to patients, and the move towards natural treatments is increasing, much the way it did in the first 1900’s, prior to the dawn of corrupt medication, pharmaceuticals, and radiation. An elevated level of toxicity is actually the last thing any human being needs when fighting an infection, disease, or pneumonia. Auto-immune disorders are mainly caused when human beings ingest chemicals from meals, drinking water, vaccines contaminated with chemicals, artificial sweeteners and environmental pollution. Chemotherapy, like the popular Cis-platinum, fills the physical body with horrific poisons, and scientists and doctors understand it, but because the FDA outlaws doctors from suggesting or prescribing vitamin supplements, supplements, herbs and super-foods, chemical therapy continues to be ‘recommended.’ The best way to beat cancer is to detoxify your body and build up your host disease fighting capability, not really break it down further by dousing one tumor or one organ with chemicals that pollute the entire system.